{"title":"Exceptional renal metastasis from adenoid cystic carcinoma of nasopharynx seen on <sup>18</sup>F-FDG PET/CT.","authors":"Yutang Yao, Rui Huang","doi":"10.1967/s002449912484","DOIUrl":null,"url":null,"abstract":"<p><p>A 48-year-old man with a history of adenoid cystic carcinoma (ACC) of the nasopharynx, eight years after radio-chemotherapy, fluorine-18-fluorodeoxyglucose positron emission tomography/computed tomography (<sup>18</sup>F-FDG PET/CT) was performed for follow-up. A lobulated mass with moderate and heterogeneous <sup>18</sup>F-FDG uptake in the right kidney was observed, which was pathologically proven as ACC metastasis.</p>","PeriodicalId":12871,"journal":{"name":"Hellenic journal of nuclear medicine","volume":null,"pages":null},"PeriodicalIF":0.9000,"publicationDate":"2022-05-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Hellenic journal of nuclear medicine","FirstCategoryId":"3","ListUrlMain":"https://doi.org/10.1967/s002449912484","RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"2022/8/3 0:00:00","PubModel":"Epub","JCR":"Q4","JCRName":"RADIOLOGY, NUCLEAR MEDICINE & MEDICAL IMAGING","Score":null,"Total":0}
引用次数: 0
Abstract
A 48-year-old man with a history of adenoid cystic carcinoma (ACC) of the nasopharynx, eight years after radio-chemotherapy, fluorine-18-fluorodeoxyglucose positron emission tomography/computed tomography (18F-FDG PET/CT) was performed for follow-up. A lobulated mass with moderate and heterogeneous 18F-FDG uptake in the right kidney was observed, which was pathologically proven as ACC metastasis.
期刊介绍:
The Hellenic Journal of Nuclear Medicine published by the Hellenic Society of
Nuclear Medicine in Thessaloniki, aims to contribute to research, to education and
cover the scientific and professional interests of physicians, in the field of nuclear
medicine and in medicine in general. The journal may publish papers of nuclear
medicine and also papers that refer to related subjects as dosimetry, computer science,
targeting of gene expression, radioimmunoassay, radiation protection, biology, cell
trafficking, related historical brief reviews and other related subjects. Original papers
are preferred. The journal may after special agreement publish supplements covering
important subjects, dully reviewed and subscripted separately.